hepatitis c

1. Introduction and Significance Sofosbuvir represents a paradigm shift in the management of chronic hepatitis C virus (HCV) infection, particularly since its approval by the FDA in 2013. As a direct-acting antiviral (DAA), sofosbuvir targets HCV replication at the molecular level, offering high cure rates and improved tolerability compared to older interferon-based regimens. Its introduction…